Items tagged with Research and development

VALIDATE: New international vaccine R&D network established (post)

The UK’s Medical Research Council (MRC) has awarded funds to Prof Helen McShane (University of Oxford) and Associate Prof Helen Fletcher (London School of Hygiene & Tropical Medicine) to set up 'VALIDATE', an international network of researchers developing vaccines against globally significant diseases caused by complex intracellular pathogens.

TB epidemic desperately needs new vaccination strategies (post)

At the beginning of November, a tuberculosis (TB) outbreak in Minnesota killed six people and made front page news. A single case in New York State made regional news last week. And so it goes, here in the U.S.. Wherever it appears, TB is an unexpected and frightening intrusion likely to draw media attention.

Incentivizing new vaccine development (post)

The flaws in a system appear most vividly when it fails where it is most required to work. Tuberculosis (TB) is one of India’s severest health crises. It kills two Indians every 3 minutes and more than 1,000 people every day. India accounts for 27% of the world’s 10.4 million new TB cases, and 29% of the 1.8 million TB deaths globally. Surely, this says something about the crisis in our public health policy.

R&D for neglected diseases reliant on just two donors, G-FINDER report warns (post)

LONDON, 14 December 2017 — Funding for research and development into neglected diseases has increased for the first time in recent years, driven by investments from the United States, a new report has found.

Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come (post)

Otsuka to advance development of novel TB compound (post)

Otsuka awarded grant to advance development of novel TB compound OPC-167832 with delamanid

Inovio and The Wistar Institute receive more than $4.6 million in R&D funding to advance vaccines against TB & malaria (post)

PLYMOUTH MEETING, Pa., Feb. 12, 2018 -- Inovio Pharmaceuticals, Inc. today announced that the company is collaborating with The Wistar Institute to advance two novel SynCon^® vaccine programs against tuberculosis (TB) and malaria, fully funded by more than $4.6 million in total grants from the Bill & Melinda Gates Foundation and the National Institutes of Health (NIH).

5th Global Forum on TB Vaccines: Call to accelerate global funding on TB vaccine research (post)

The 5^th Global Forum on TB Vaccines commenced today (February 20) in New Delhi. The Forum is a scientific conference, which provides a platform for researchers, clinicians, product developers, policymakers, advocates, and other stakeholders, to review the state of the field, share the latest research and findings with the end goal of developing new TB vaccines. Experts agreed that there is an urgent need to develop an effective vaccine against both drug-sensitive and drug-resistant (Multi-Drug Resistant and Totally Drug Resistant) TB. The target set forth in the WHO End TB Strategy to end the TB epidemic by 2035 cannot be achieved without new vaccines, as well as improved diagnostics and treatment. The Inaugural Ceremony was attended by the Minister of State for Health and Family Welfare, Ms. Anupriya Patel; Deputy Director General (Programmes), World Health Organization, Dr Soumya Swaminathan; Secretary, Department of Biotechnology, Dr Ashutosh Sharma; Secretary, Ministry of Health and Family Welfare, Ms Preeti Sudan; and other key dignitaries.

Genedrive surges after receiving £1.1mln in funding to finance development of its TB testing kit (post)

"We are very appreciative of Innovate UK's support and recognition of our commitment to TB diagnostics," said Genedrive CEO, David Budd

Why do so many South Africans die of TB? (post)

GroundUp featured a three-part series on TB which kills over 100,000 South Africans every year.